BOSTON, MA, February 02, 2016 /24-7PressRelease/ -- Ceeable, Inc. was selected as a finalist for its mobile digital health technology at the IDEA Showcase@ITEXPO conference in Ft. Lauderdale Florida January 27-29 2016. The Ceeable Visual Field Analyzer (CVFA) is a cloud-based digital platform used to detect and diagnose retinal disease, including glaucoma, diabetic retinopathy and macular degeneration. The CVFA will deliver rapid, accurate and low-cost visual testing to patient populations that may not have access to traditional visual testing services.
IDEA Showcase was is a forum for companies to present business models that rely on modern telecommunications networks. There is a strong emphasis on enabling technologies that take advantage of the current infrastructure and the Ceeable mobile technology uses mobile networks to deliver a breakthrough product to detect retinal disease.
The CVFA can be used in both traditional clinical settings for visual exams and non-traditional settings, from shopping malls to villages. The CVFA is highly mobile and can be accessed from anywhere at any time using a tablet computer and internet connection. This flexibility provides much greater access to patients and caregivers. The Ceeable technology has been used to detect retinal disease on thousands of patients worldwide.
About Ceeable
Ceeable, Inc. is a leader in digital mobile health for ophthalmology. The Ceeable Visual Field Analyzer (CVFA) is cloud-based digital platform used to detect and diagnose retinal disease. There are more that 300 million people worldwide that suffer from retinal disease. The Ceeable technology has the ability to reach more people worldwide than any currently available retinal diagnostic technology. Better patient management of eye disease will reduce healthcare systems costs and help to prevent blindness.
# # #